Efficacy and Tolerability of DTG Plus 3TC in HIV Infected Adults With Virologically Suppression and TDF Toxicity

Clinical trial NCT05493969 · UNKNOWN

Trial details

NCT number: NCT05493969
Sponsor: Shanghai Public Health Clinical Center
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Acquired Immunodeficiency Syndrome

Start date: 2022-08-01
Primary completion: 2025-08-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.